Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity - Mustang Bio stock option activities (Detail)

v3.8.0.1
Stockholders’ Equity - Mustang Bio stock option activities (Detail)
9 Months Ended
Sep. 30, 2017
$ / shares
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 1,085,501
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Granted, Weighted Average Remaining Contractual Term 9 years 6 months 22 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Outstanding, Weighted Average Remaining Contractual Term 9 years 6 months 22 days
Mustang Bio, Inc [Member]  
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares 0
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 1,241,675
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares 1,241,675
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 0
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Granted, Weighted Average Price | $ / shares $ 5.73
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Outstanding , Weighted Average Price | $ / shares $ 5.73